MET and hepatocellular carcinoma: Aberrant activation of c-MET can lead to tumor progression, invasive growth, angiogenesis, metastasis, and resistance to therapies, and plays a vital role in the treatment of tumors, especially hepatocellular carcinoma; therefore, c-MET has become a popular target for tumor treatment [20].